LSA
DXCM icon

L & S Advisors’s DexCom DXCM Stock Holding History

L & S Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,245
Closed -$958K – 318
2023
Q1 		$958K Sell
8,245
-136
-2% -$15.2K 0.13% 159
2022
Q4 		$949K Sell
8,381
-2,312
-22% -$254K 0.18% 130
2022
Q3 		$861K Sell
10,693
-4,575
-30% -$387K 0.15% 134
2022
Q2 		$1.14M Buy
+15,268
New +$1.39M 0.19% 113
2020
Q4 		– Sell
-11,916
Closed -$1.23M – 342
2020
Q3 		$1.23M Sell
11,916
-228
-2% -$23.8K 0.17% 174
2020
Q2 		$1.23M Buy
12,144
+4,516
+59% +$404K 0.18% 141
2020
Q1 		$513K Buy
+7,628
New +$475K 0.1% 172
2019
Q2 		– Sell
-20,520
Closed -$611K – 337
2019
Q1 		$611K Buy
+20,520
New +$721K 0.08% 215
2018
Q4 		– Sell
-72,784
Closed -$2.6M – 309
2018
Q3 		$2.6M Buy
72,784
+116
+0.2% +$3.6K 0.34% 75
2018
Q2 		$1.73M Buy
+72,668
New +$1.54M 0.29% 90

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

L & S Advisors's DXCM Position: Q2 2023 in Review

L & S Advisors sold out of DexCom (DXCM) in Q2 2023, closing a stake of 8,245 shares — an estimated $958K sold.

L & S Advisors first reported a position in DXCM in Q2 2018 and held it in 10 quarters. The position peaked at $2.6M in Q3 2018. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • L & S Advisors reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
  • L & S Advisors sold 8,245 DexCom shares in Q2 2023, an estimated $958K.
  • L & S Advisors first reported a position in DexCom in Q2 2018 and held it in 10 quarters.
  • L & S Advisors's DexCom position peaked at $2.6M in Q3 2018.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on L & S Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.